All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @sirmixaflock on TikTok · 73s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @sirmixaflock's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00It's confession time. I lost 36 pounds in four months while taking compound semaglutide.
  2. 0:04I took my last shot of semaglutide four months ago and have since gained back eight pounds, proving that everybody in my comments was right and I was wrong.
  3. 0:12The moment you stop taking this medicine, you're gonna gain it all back.
  4. 0:16And it has nothing to do with the fact that I've been stress drinking every night for the past three months in anticipation of our election.
  5. 0:21Or that I've been door dashing in post-mating most of my paycheck because I've been working 16 hour days six days a week.
  6. 0:27It has nothing to do with the fact that I haven't been following a fitness program, that I've done zero minutes of cardio in the past three months, six months of being honest.
  7. 0:35It has nothing to do with the fact that I've been getting five hours of sleep and hyper-caffeinating and under-hydrating.
  8. 0:41And it also has nothing to do with the fact that my body has been used to being around 200 pounds for the past 10 years.
  9. 0:47And for the first time in my life, I set it outside of its baseline by coming at 195 pounds.
  10. 0:53It has nothing to do with any of the things that will require me to take any personal responsibility or accountability and everything to do with big fucking pharma that's trying to bleed us dry of our hard-earned cash until the day that we die.
  11. 1:07Sounds a little crazy, right?

@sirmixaflock's GLP-1 correction claims, fact-checked

Evan

TikTok creator

19.5K viewsWatch on TikTok

Quick answer

The creator discontinued compound semaglutide after approximately four months of use and experienced eight pounds of weight regain over the following four months, concurrent with self-reported alcohol use, sleep deprivation, physical inactivity, and poor dietary habits. Weight regain after GLP-1 discontinuation is pharmacologically expected, as appetite suppression and gastric motility effects reverse when the drug is stopped, but the lifestyle factors described independently drive positive energy balance and make it impossible to attribute the regain to the medication alone. Clinicians generally recommend behavioral and dietary habit-building during GLP-1 treatment to support weight maintenance if and when the medication is eventually stopped.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

GLP-1 social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 9 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @sirmixaflock's GLP-1 correction claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@sirmixaflock's GLP-1 correction claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@sirmixaflock's GLP-1 correction claims, fact-checked" from Evan. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator discontinued compound semaglutide after approximately four months of use and experienced eight pounds of weight regain over the following four months, concurrent with self-reported alcohol use, sleep deprivation, physical inactivity, and poor dietary habits.

The reason this review is not generic is the source wording and the canonical claim label "glp1 i m not too proud to admit when im wrong." In this clip, the useful excerpt is: "It's confession time." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Sleep deprivation independently drives weight gain: Spiegel et al.
People who land here are usually trying to understand whether the GLP-1 social video fact-checks claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' GLP-1 social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator discontinued compound semaglutide after approximately four months of use and experienced eight pounds of weight regain over the following four months, concurrent with self-reported alcohol use, sleep deprivation, physical inactivity, and poor dietary habits.

FormBlends verdict

GLP-1 social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator discontinued compound semaglutide after approximately four months of use and experienced eight pounds of weight regain over the following four months, concurrent with self-reported alcohol use, sleep deprivation, physical inactivity, and poor dietary habits. Weight regain after GLP-1 discontinuation is pharmacologically expected, as appetite suppression and gastric motility effects reverse when the drug is stopped, but the lifestyle factors described independently drive positive energy balance and make it impossible to attribute the regain to the medication alone. Clinicians generally recommend behavioral and dietary habit-building during GLP-1 treatment to support weight maintenance if and when the medication is eventually stopped.
  • Wilding et al. (2022, NEJM) found patients regained roughly two-thirds of semaglutide-driven weight loss within one year of stopping the drug, so regain is real, but the creator regained only eight of 36 pounds after four months, which is below that trajectory.
  • Sleep deprivation independently drives weight gain: Spiegel et al. (2004, Annals of Internal Medicine) showed that even modest sleep restriction elevates ghrelin and suppresses leptin, increasing appetite significantly.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Wilding et al. (2022, NEJM) found patients regained roughly two-thirds of semaglutide-driven weight loss within one year of stopping the drug, so regain is real, but the creator regained only eight of 36 pounds after four months, which is below that trajectory.
  • Sleep deprivation independently drives weight gain: Spiegel et al. (2004, Annals of Internal Medicine) showed that even modest sleep restriction elevates ghrelin and suppresses leptin, increasing appetite significantly.
  • Alcohol contributes caloric load and impairs food-related decision-making; nightly drinking over three to four months is not a neutral lifestyle variable when evaluating weight changes.
  • The STEP 5 trial (Garvey et al., 2022, Nature Medicine) showed that two years of continuous semaglutide treatment maintained significantly greater weight loss than shorter courses, supporting long-term use for patients who need it rather than stopping arbitrarily.
  • GLP-1 medications suppress appetite through receptor agonism that reverses when the drug is stopped; this is pharmacology, not a conspiracy, and applies to virtually all appetite-regulating medications.
  • Compounded semaglutide is not equivalent to FDA-approved branded formulations; patients using compound versions should understand they are not taking the same product reviewed in published clinical trials.
  • Behavioral habits built during GLP-1 treatment, exercise, sleep, reduced alcohol, dietary patterns, are the primary determinants of whether weight is maintained after stopping; the creator's own account suggests those habits were not in place.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @sirmixaflock actually say?

The creator lost 36 pounds over four months on compound semaglutide, stopped four months ago, and has since regained eight pounds. They sarcastically dismissed their own lifestyle changes, including nightly stress drinking, zero cardio, five hours of sleep, and heavy takeout spending, as irrelevant. Their conclusion: "big fucking pharma" is to blame, not personal behavior. But here's the thing, they actually undercut their own argument in real time, and pretty effectively.

The video is framed as a confession and a concession to commenters who said weight regain is inevitable after stopping GLP-1 medications. The creator seems to genuinely believe that, despite spending 90 seconds listing every modifiable lifestyle factor that contributes to weight regain. That tension is worth examining carefully.

Does the science back this up?

Partially, but not in the way the creator thinks. Yes, weight regain after stopping semaglutide is real and well-documented. But eight pounds after four months off the drug, in the context of the lifestyle the creator described, is not evidence that the drug itself is a trap.

The STEP 1 trial extension (Wilding et al., 2022, New England Journal of Medicine) followed patients who stopped semaglutide after 68 weeks. Within one year off the drug, participants regained about two-thirds of their lost weight on average. That is a real and significant finding. But those participants were not stress drinking nightly, sleeping five hours, skipping all exercise, and eating delivery food on a 16-hour workday schedule. The STEP 1 withdrawl cohort was simply stopping the drug under relatively controlled conditions. The creator is doing that plus introducing nearly every known driver of weight regain simultaneously.

Sleep deprivation alone, documented in work by Spiegel et al. (2004, Annals of Internal Medicine), meaningfully disrupts ghrelin and leptin signaling in ways that increase appetite and reduce satiety. Alcohol adds caloric load and impairs prefrontal decision-making around food choices. These are not minor confounders.

What did they get wrong (or right)?

They got one thing genuinely right: GLP-1 medications do not produce permanent weight loss after discontinuation for most people. That is not a pharma conspiracy, it is pharmacology. Semaglutide suppresses appetite through receptor agonism that stops when you stop the drug. Your hunger signaling rebounds. This is well-established.

What they got wrong is the implied math. Eight pounds over four months, given the lifestyle factors they described, is actually a relatively modest regain. Someone who drank nightly, stopped all exercise, slept poorly, and ate restaurant food for four months without any pharmaceutical support might expect to gain considerably more. The drug's residual behavioral effects, and possibly some metabolic adaptation, may still be doing some work.

The creator also conflated "weight regain happens" with "all weight regain is caused by stopping the drug." Those are different claims. One is supported by evidence. The other ignores that the human body has multiple, interacting systems that regulate weight, and the creator disrupted most of them at once.

Framing this as a pharmaceutical industry scheme is where the argument falls apart. There is legitimate criticism to be made about drug pricing and access. But eight pounds of regain during four months of documented high-stress, low-sleep, alcohol-heavy living is not evidence of a conspiracy. It is evidence of energy balance.

What should you actually know?

GLP-1 receptor agonists are not a permanent fix if stopped, but they are also not a scam designed to create dependency. The biology here is consistent: the drug reduces appetite and slows gastric emptying, and when you remove it, those effects reverse. Research from the STEP 5 trial (Garvey et al., 2022, Nature Medicine) showed that continuous treatment over two years maintained significantly greater weight loss than what is seen after stopping. The drug works while you take it.

What this video actually demonstrates, unintentionally, is that weight management involves multiple systems at once. Sleep, stress, alcohol, physical activity, and medication all interact. Removing one variable, the drug, while adding several unfavorable ones does not isolate the drug's effect. It just makes everything harder.

If you are considering stopping a GLP-1 medication, talk to a clinician about tapering strategies, behavioral support, and realistic expectations. The research suggests that some patients can maintain weight loss after stopping if they have built durable habits during treatment. The creator, by their own admission, had not done that. That is worth being honest about.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Evan · TikTok creator

19.5K views on this video

I’m not too proud to admit when im wrong

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about wilding et al. (2022, nejm) found patients regained roughly two-thirds?

Wilding et al. (2022, NEJM) found patients regained roughly two-thirds of semaglutide-driven weight loss within one year of stopping the drug, so regain is real, but the creator regained only eight of 36 pounds after four months, which is below that trajectory.

What does the video say about sleep deprivation independently drives weight gain: spiegel et al. (2004,?

Sleep deprivation independently drives weight gain: Spiegel et al. (2004, Annals of Internal Medicine) showed that even modest sleep restriction elevates ghrelin and suppresses leptin, increasing appetite significantly.

What does the video say about alcohol contributes caloric load?

Alcohol contributes caloric load and impairs food-related decision-making; nightly drinking over three to four months is not a neutral lifestyle variable when evaluating weight changes.

What does the video say about the step 5 trial (garvey et al., 2022, nature medicine)?

The STEP 5 trial (Garvey et al., 2022, Nature Medicine) showed that two years of continuous semaglutide treatment maintained significantly greater weight loss than shorter courses, supporting long-term use for patients who need it rather than stopping arbitrarily.

What does the video say about glp-1 medications suppress appetite through receptor agonism?

GLP-1 medications suppress appetite through receptor agonism that reverses when the drug is stopped; this is pharmacology, not a conspiracy, and applies to virtually all appetite-regulating medications.

What does the video say about compounded semaglutide?

Compounded semaglutide is not equivalent to FDA-approved branded formulations; patients using compound versions should understand they are not taking the same product reviewed in published clinical trials.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Evan, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.